Skip to content
HowShorted

REGENXBIO Inc. short interest in 2020

In 2020, REGENXBIO Inc.'s disclosed short interest ran from 11.40% of shares outstanding on 15 Jan 2020 to 7.40% on 31 Dec 2020, a change of -4.00 percentage points. The year's high was 13.38% on 31 Jan 2020 and its low 7.40% on 31 Dec 2020, averaging 11.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.81 days on 31 Aug 2020. Full history: REGENXBIO Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REGENXBIO Inc. in 2020

2020 in figures

Start of year
11.40% (15 Jan 2020)
End of year
7.40% (31 Dec 2020)
Change
-4.00 pp
High
13.38% (31 Jan 2020)
Low
7.40% (31 Dec 2020)
Average
11.30%
Highest days to cover
16.81 (31 Aug 2020)
SEC filings marked
9

Every report in 2020

REGENXBIO Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202011.40%9.05results (8-K)
31 Jan 202013.38%12.89
14 Feb 202012.00%11.96
28 Feb 202011.68%8.5010-K filed, results (8-K)
13 Mar 202011.83%7.59
31 Mar 202012.37%7.10
15 Apr 202011.79%11.08
30 Apr 202010.86%11.75
15 May 202011.36%9.6310-Q filed, results (8-K)
29 May 202011.16%14.56
15 Jun 202011.52%10.27
30 Jun 202011.47%10.13
15 Jul 202011.78%15.68
31 Jul 202011.54%16.77
14 Aug 202011.97%16.7910-Q filed, results (8-K)
31 Aug 202012.28%16.81
15 Sep 202012.25%15.26
30 Sep 202011.63%9.85
15 Oct 202012.38%14.53
30 Oct 202011.55%14.23
13 Nov 202010.25%8.8810-Q filed, results (8-K)
30 Nov 20208.66%12.59
15 Dec 20208.80%9.00
31 Dec 20207.40%6.71

See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.